There are 2949 resources available
Pioneering with PARP inhibition: rationale for maintenance therapy in newly diagnosed ovarian cancer
Presenter: Thomas Herzog
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Optimising clinical outcomes: the case for personalised medicine in ovarian cancer
Presenter: Ignace Vergote
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Panel discussion
Presenter: Ignace Vergote
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Summary and meeting close
Presenter: Ana Oaknin
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Predictors of treatment outcomes in patients with advanced ovarian cancer
Presenter: Bradley Monk
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Evaluating first-line maintenance therapy options
Presenter: Antonio González Martín
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
The role of genetic testing in the treatment decision-making process
Presenter: Kathleen Moore
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
PARPi in the treatment of recurrent disease
Presenter: Jonathan Ledermann
Session: GSK - Treatment options for women with advanced ovarian cancer: Evaluating the evidence
Resources:
Webcast
Chair’s welcome and introductions
Presenter: Neal Shore
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
The biology of breast cancer: Lessons from the past
Presenter: Sandra Swain
Session: F. Hoffmann-La Roche - Advancing Knowledge in Early and Metastatic Triple-Negative Breast Cancer
Resources:
Webcast